LIU WEIMIN
No ORCID on file
· 21 papers in corpus
· active 2003-2009
Frequent coauthors
2009
Disclosed are compounds of formulae (I) and (II), wherein the substituents are as defined in the specification, compositions comprising the compounds and processes for their preparation. The compounds are selective, reversible inhibitors of…
2009
Disclosed are compounds of formulae (I) and (II), wherein the substituents are as defined in the specification, compositions comprising the compounds and processes for their preparation. The compounds are selective, reversible inhibitors of…
2009
Disclosed are compounds of formulae (I) and (II), wherein the substituents are as defined in the specification, compositions comprising the compounds and processes for their preparation. The compounds are selective, reversible inhibitors of…
2009
Disclosed are compounds of formulae (I) and (II), wherein the substituents are as defined in the specification, compositions comprising the compounds and processes for their preparation. The compounds are selective, reversible inhibitors of…
2009
Disclosed are compounds of formulae (I) and (II), wherein the substituents are as defined in the specification, compositions comprising the compounds and processes for their preparation. The compounds are selective, reversible inhibitors of…
2009
Disclosed are compounds of formulae (I) and (II), wherein the substituents are as defined in the specification, compositions comprising the compounds and processes for their preparation. The compounds are selective, reversible inhibitors of…
2009
Disclosed are compounds of formulae (I) and (II), wherein the substituents are as defined in the specification, compositions comprising the compounds and processes for their preparation. The compounds are selective, reversible inhibitors of…
2005
Compounds according to the following formula (I):wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such…
2005
Compounds according to the following formula (I):wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such…
2005
Compounds according to the following formula (I):wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such…
2005
Compounds according to the following formula (I):wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such…
2005
Compounds according to the following formula (I):wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such…
2005
Compounds according to the following formula (I):wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such…
2005
Compounds according to the following formula (I):wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such…
2003
Compounds according to formula (I) wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such compounds, an…
2003
Compounds according to formula (I) wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such compounds, an…
2003
Compounds according to formula (I) wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such compounds, an…
2003
Compounds according to formula (I) wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such compounds, an…
2003
Compounds according to formula (I) wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such compounds, an…
2003
Compounds according to formula (I) wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such compounds, an…
2003
Compounds according to formula (I) wherein the variables Q and R1 to R6 are as described herein, which reversibly inhibit the cysteine proteases, such as cathepsins K, S, F, L and B; pharmaceutical compositions containing such compounds, an…